Government response to ACMD report on barriers to research

Government is establishing a cross-government officials working group to focus on new issues involving research with controlled drugs. Research using Schedule 1 Controlled Drugs in universities and hospitals will no longer need a Home Office licence, nor will clinical trials with relevant HRA and MHRA approvals.